Core Insights - PACS Group, Inc. is under investigation for potential violations of federal securities laws following allegations of financial misconduct related to Medicare benefits [1][3] - A report by Hindenburg Research claims PACS engaged in fraudulent practices that inflated its financial performance, leading to a significant stock price drop [2][3] Company Overview - PACS Group is one of the largest operators of skilled nursing facilities in the United States, promoting a "turnaround" strategy to enhance profitability [2] - The company went public in early 2024, presenting an image of legitimate growth and profitability [3] Allegations and Impact - Hindenburg Research's report alleges that PACS abused COVID-era waivers to improperly access Medicare benefits, which contributed to over 100% of its operating and net income from 2020 to 2023 [3] - Following the report's release on November 4, 2024, PACS's stock price plummeted by 27.8%, from $42.94 to $31.01 per share [3]

NEWTOWN, Pa., Nov. 10, 2024 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving PACS Group Inc. (NASDAQ: PACS) resulting from allegations of providing misleading business information to the investing public.If you have non-public information that could assist in the PACS Group Inc. investigation or if you are a PACS Group Inc. investor who suffered a loss and would like to learn more, you can provide your information HERE.You can also contact a ...

RADNOR, Pa., Nov. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of PACS Group, Inc. (NYSE: PACS) (“PACS”). On November 4, 2024, Hindenburg Research published a report titled: "PACS Group: How to Become A Billionaire In The Skilled Nursing Industry By Systematically Scamming Taxpayers." Specifically, the report indicated after a 5-month investigation that incl ...

NEW YORK, Nov. 10, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into PACS Group, Inc. (NYSE: PACS) for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/pacs-group-inc. Why Did PACS's Stock Drop? PACS is one of the largest operators of skilled nursing facilities in the United States. PACS has repeatedly represent ...

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of PACS Group, Inc. due to allegations of materially misleading business information issued by the company [1] Group 1: Investigation and Allegations - PACS Group may have issued misleading information to the investing public, prompting an investigation by Rosen Law Firm [1] - Hindenburg Research published a report alleging that PACS Group's turnaround strategy for skilled nursing facilities involves scamming taxpayer-funded healthcare programs, leading to a significant stock price drop of 27.7% on November 4, 2024 [3] Group 2: Class Action and Compensation - Investors who purchased PACS Group securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Rosen Law Firm is preparing a class action to seek recovery of investor losses [2] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

Group 1 - The law firm Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of investors of PACS Group, Inc. (NYSE: PACS) [1] - Hindenburg Research published a report alleging that PACS Group systematically scammed taxpayers by abusing a COVID-era waiver to access Medicare benefits for thousands of patients, which significantly inflated its operating and net income from 2020 to 2023 [2] - Following the report, PACS' stock price dropped 27.8%, from $42.94 per share on November 1, 2024, to $31.01 per share on November 4, 2024 [2]

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of PACS Group, Inc. (NYSE: PACS) resulting from allegations that PACS Group may have issued materially misleading business information to the investing public. So What: If you purchased PACS Group securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

LOS ANGELES, Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE: PACS) for violations of the securities laws. According to the Complaint, the Company made false and misleading statements to the market. PACS Group is the subject of a report issued by Hindenburg Research on November 4, 2024, titled: "PACS Group: How to Become A Billionaire In ...

Core Viewpoint - PACS Group, Inc. is under investigation for potential securities law violations following a significant drop in share price due to allegations of improper revenue inflation related to Medicare [2][4]. Group 1: Company Performance - PACS Group shares have decreased by over 50% this week [2]. - The company postponed its Q3 earnings report after a Hindenburg Research report raised concerns about the misuse of COVID waivers from 2020 to 2023 [2]. Group 2: Legal Investigation - Block & Leviton is investigating PACS Group for possible securities law violations and may file actions to recover losses for affected investors [4][7]. - Investors who have lost money in PACS Group are encouraged to contact Block & Leviton for potential recovery options [5][6]. Group 3: Investor Eligibility - Any individual who purchased PACS Group common stock and experienced a decline in share value may be eligible for recovery, regardless of whether they sold their investment [3].

SAN FRANCISCO, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of PACS (NYSE: PACS) investors. If you are an PACS Group, Inc. investor with losses, please fill out this form, email apolk@girardsharp.com, or call (866) 981-4800 for a free consultation. On November 4, 2024, Hindenburg Research published an article detailing PACS Group, INC’s “turnaround” formula for transforming poorl ...